Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of Humanin treatment on brain tumor cell lines

ABSTRACT: Effect of Humanin treatment on brain tumor cell lines

PROVIDER: PRJEB64793 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR11798800.fastq.gz	Fastqsanger.gz
	ERR11798801.fastq.gz	Fastqsanger.gz
	ERR11798802.fastq.gz	Fastqsanger.gz
	ERR11798803.fastq.gz	Fastqsanger.gz
	ERR11798804.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

Effect of Humanin treatment on brain tumor vascular cells

Project description:Effect of Humanin treatment on brain tumor vascular cells

| PRJEB75574 | ENA

Effect of demeclocycline on brain tumor initiating cells

Project description:We have determined that demeclocycline reduces the growth of brain tumor initiating cells (BTICs). Specifically, we sought to obtain insights into the mechanisms by which demeclocycline directly regulates BTIC growth. Analysis of the array data identified several genes that were altered with demeclocycline treatment that could regulate BTIC growth. The study provides the mechanistic basis for the regulation of BTIC growth with demeclocycline treatment. We subjected 3 BTIC lines to microarray analyses to identify genes involved in the regulation of BTIC growth by demeclocycline. Three BTIC lines (BT012, BT025 and BT048) were treated with 10 ÂµM demeclocycline for 6h. One (1) control and 1 treatment (demeclocycline treated) sample was generated from each BTIC line. Thus, a total of 6 RNA samples from 3 BTIC lines were obtained for microarray analysis.

2016-05-18 | E-GEOD-81515 | biostudies-arrayexpress

Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines

Project description:Small-molecule tankyrase 1 and tankyrase 2 (TNKS1/2) inhibitors are effective anti-tumor agents in selected tumor cell lines and mouse models. Here, we characterized the response signatures and the in-depth mechanisms for the anti-proliferative effect of tankyrase inhibition (TNKSi). The TNKS1/2-specific inhibitor G007-LK was used to screen 537 human tumor cell lines and a panel of in particular TNKSi-sensitive tumor cell lines was identified. Transcriptome, proteome and bioinformatic analyses revealed the overall TNKSi-induced response signatures in the selected panel. TNKSi-mediated inhibition of WNT/β-catenin, YAP and PI3K/AKT signaling was validated and correlated with lost expression of the key oncogene MYC and impaired cell growth. Moreover, we show that TNKSi induces accumulation of TNKS1/2-containing β-catenin degradasomes functioning as central complexes interacting with YAP and AMOT proteins during attenuation of YAP signaling. These findings provide a contextual and mechanistic framework for using TNKSi in anti-cancer treatment that warrants further comprehensive preclinical and clinical evaluations.

2021-09-09 | PXD022908 | Pride

Effect of TGFb/MEKi treatment on human melanoma cell lines

Project description:Effect of TGFb/MEKi treatment on human melanoma cell lines

| PRJNA1090036 | ENA

Effect of Omomyc treatment on human lung adenocarcinoma cell lines

Project description:Effect of Omomyc treatment on human lung adenocarcinoma cell lines

| PRJNA521969 | ENA

Iarosz2015 - brain tumor

Project description:The paper describes a model of brain tumor. Created by COPASI 4.25 (Build 207) This model is described in the article: Mathematical model of brain tumour with glia-neuron interactions and chemotherapy treatment Kelly C. Iarosz, Fernando S. Borges, Antonio M. Batista, Murilo S. Baptista, Regiane A. N. Siqueira, Ricardo L. Viana, Sergio R. Lopes Abstract: In recent years, it became clear that a better understanding of the interactions among the main elements involved in the cancer network is necessary for the treatment of cancer and the suppression of cancer growth. In this work we propose a system of coupled differential equations that model brain tumour under treatment by chemotherapy, which considers interactions among the glial cells, the glioma, the neurons, and the chemotherapeutic agents. We study the conditions for the glioma growth to be eliminated, and identify values of the parameters for which the inhibition of the glioma growth is obtained with a minimal loss of healthy cells. To cite BioModels Database, please use: BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models . To the extent possible under law, all copyright and related or neighbouring rights to this encoded model have been dedicated to the public domain worldwide. Please refer to CC0 Public Domain Dedication for more information.

2024-09-02 | BIOMD0000000775 | BioModels

Effect of glutamine treatment on human brain microvascular endothelial cells

Project description:Effect of glutamine treatment on human brain microvascular endothelial cells

| PRJNA1081456 | ENA

Effect of VEGF-C treatment on sorted brain microglia/macrophages

Project description:Effect of VEGF-C treatment on sorted brain microglia/macrophages

| PRJNA1061529 | ENA

Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines

Project description:Anti-cancer treatment, using small-molecule tankyrase 1 and tankyrase 2 (TNKS1/2) inhibition (TNKSi) shows effect against selected tumor cell lines and in mouse models. Here, we characterize the responsiveness signatures and in depth mechanisms for the anti-proliferative effect of TNKSi. The TNKS1/2-specific inhibitor G007-LK was screened against 537 human tumor cell lines, and a panel of in particular TNKSi-sensitive tumor cell lines was identified. Transcriptome, proteome and bioinformatic analyses classified the overall TNKSi-induced response signatures in the selected panel. Prediction of TNKSi-mediated inhibition of WNT/β-catenin, YAP and PI3K/AKT signaling was validated and correlated with lost expression of the key oncogene MYC and impaired cell growth. Moreover, we show that TNKSi, when attenuating YAP signaling, induces accumulation of TNKS1/2-containing β-catenin degradosomes functioning as central complexes interacting with YAP and AMOT proteins. The findings provide a contextual and mechanistic framework for TNKSi in cancer cell lines rationalizing further comprehensive preclinical and clinical evaluations.

2021-06-18 | GSE162648 | GEO

Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines

Project description:Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines

| PRJNA682539 | ENA